SSB Global Journal of Medical Science

Impact of Gestational Diabetes and Pre-existing Diabetes in Fetal Outcome among Pregnancy Cases of Rangpur

Nahida Sultana — Wed, 27 Dec 2023 00:00:00 +0000

Introduction: Diabetes in pregnancy, including gestational and pre-gestational diabetes, presents significant risks to both maternal and fetal health. Understanding the impact of these conditions on pregnancy outcomes is crucial for developing effective management strategies.

Methods: This observational comparative study involved 300 pregnant women at Rangpur Medical College Hospital, divided into three groups: pre-gestational diabetic (Group A), gestational diabetic (Group B), and non-diabetic control (Group C). Data on socio-demographic characteristics, obstetric profiles, mode of delivery, maternal complications, and fetal outcomes were collected and analyzed.

Result: The study meticulously analyzed socio-demographic characteristics, revealing no significant differences across the groups. In obstetric profiles, Group A (Pre-Gestational Diabetic) had a notably lower mean gestational age at delivery (36.06 ± 2.71 weeks) compared to Group B (Gestational Diabetic) and Group C (Control), with mean ages of 37.34± 1.12 and 38.46±1.13 weeks, respectively. Maternal complications were significantly higher in Group A at 47%, compared to 25% in Group B and 12% in Group C. Fetal outcomes showed marked variations: Group A had 95% stable births, 5% stillbirths, and 60% of neonates with Apgar scores ≤7 at 5 minutes. In contrast, Group B had 96% stable births, 4% stillbirths, and 27% of neonates with Apgar scores ≤7, while Group C reported 100% stable births and 11% with Apgar scores ≤7. Birth weight distribution indicated 24% of neonates in Group A weighed <2 kg, compared to 5% in Group B and 4% in Group C. NICU admissions were highest in Group A (44%), followed by Group B (29%) and Group C (11%). Perinatal complications like birth asphyxia (38% in Group A, 16% in Group B, 6% in Group C), hypoglycemia (22% in Group A, 10% in Group B, 4% in Group C), and hyperbilirubinemia (16% in Group A, 12% in Group B, 0% in Group C) were also significantly higher in diabetic groups.

Conclusion: The presence of gestational or pre-gestational diabetes in mothers significantly impacts fetal outcomes and increases the risk of maternal complications. This study highlights the need for specialized care and vigilant monitoring in pregnancies complicated by diabetes to improve health outcomes for mothers and babies.

Epidemiological Analysis of Dengue Cases and Deaths: Gender Disparities and Age-Related Trends.

Tue, 21 Nov 2023 00:00:00 +0000

Conference: 9th International Public Health Conference ( Bangladesh Medical Research Council Auditorium, Mohakhali, Dhaka. November 17-18, 2023)

Our study aimed to analyze dengue cases and deaths, focusing on gender and age trends. Data from healthcare sources were retrospectively examined, revealing a 61% male to 39% female ratio in cases. Deaths, however, showed a 43% male to 57% female ratio. The 31-60 age group was most affected, constituting 48% of deaths, with 82% occurring within 1-3 days of hospitalization. Notably, the Case Fatality Rate was higher in females (0.71%) than males (0.34%). Serotyping of 445 samples indicated DENV-2 (65.6%) as the predominant serotype. Our findings stress the need for targeted interventions, considering gender and age disparities, and prompt care for Dengue Shock Syndrome.

The Future of Medicine: Embracing Technology and Collaboration

Kariul Islam — Thu, 15 Feb 2024 00:00:00 +0000

The field of medicine stands on the cusp of a new era marked by remarkable advancements and promising possibilities. In this reflection, we acknowledge the profound impact of technology on healthcare and underscore the importance of embracing innovation while upholding core values of evidence-based practice and ethical care. The convergence of medicine and technology has sparked unprecedented innovation, revolutionizing how we diagnose, treat, and care for patients. From cutting-edge imaging techniques to personalized medicine driven by genomics, we are witnessing a transformative shift in our understanding of health and disease. Artificial intelligence and machine learning empower us to decode complex data, leading to more precise diagnoses and tailored treatment strategies. Additionally, the digitalization of healthcare through electronic records, telemedicine, and wearable devices promises to broaden patient access and enhance outcomes worldwide, a trend accelerated by the COVID-19 pandemic. Amidst these advancements, we must remain vigilant in safeguarding patient privacy and ethical principles. The future of medicine hinges not only on technological progress but also on interdisciplinary collaboration and compassionate, patient-centered care. As stewards of healthcare, we must prioritize holistic patient well-being and foster a culture of empathy and collaboration. By embracing technology while staying true to our ethical compass, we can shape a future healthcare landscape defined by improved outcomes, enhanced patient experiences, and equitable access to medical resources. We express confidence in the collective efforts of our colleagues to drive continued innovation and inspire future generations in the pursuit of better healthcare.